More on GLTO
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.70 |
|
|||
| Open | $0.70 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $0.71 | ||||
| Day Low | $0.65 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 75,622 | ||||
- Form PRE 14A Galecto, Inc. For: Jun 20
- Form 8-K Galecto, Inc. For: Mar 22
- Form S-8 Galecto, Inc.
- Form 10-K Galecto, Inc. For: Dec 31
- Form SCHEDULE 13G/A Galecto, Inc. Filed by: Otto Erik
- Form 4 Galecto, Inc. For: Jan 03 Filed by: Schambye Hans T.
- Form 4 Galecto, Inc. For: Jan 03 Filed by: Freve Jonathan
- Form 4 Galecto, Inc. For: Jan 03 Filed by: Winslow Garrett
- Form 8-K Galecto, Inc. For: Dec 21
- Galecto Inc. (GLTO) Reports Topline Results from MYLOX-1 Trial Demonstrated Reduction in Fibrosis of the Bone Marrow in Patients with Myelofibrosis
Entities mentioned with GLTO
- OrbiMed Advisors | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- IPO | View Related Stories »
- 13G | View Related Stories »
- Credit Suisse | View Related Stories »
- 13D | View Related Stories »
- Jefferies & Co | View Related Stories »
- Show More...
